# CSL Behring

CSL Behring is an Asset Manager based in King of Prussia, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** King of Prussia, United States
- **Region:** North America
- **Address:** King of Prussia, PA, United States
- **Assets under management:** Undisclosed
- **Website:** www.cslbehring.com
- **LinkedIn:** https://www.linkedin.com/company/csl

## Regulatory record

- **Reports private funds:** No

## About

CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases.

## Sectors

- Biotech
- Healthcare Services
- Immunology
- Hematology
- Cardiovascular and Metabolic
- Respiratory
- Transplant

## Questions

### Who runs investment decisions at CSL Behring?

CSL Behring is a business unit of CSL Limited, and its investment and R&D decisions are directed by the CSL executive leadership team. The firm does not publicly name individual portfolio managers or a CIO for CSL Behring specifically; strategic direction comes from the parent company's board and management (per CSL's investor relations).

### How does CSL Behring source proprietary deal flow?

CSL Behring primarily sources R&D opportunities internally via its three scientific platforms. Additionally, it engages in partnerships and acquisitions for drug candidates; examples include the acquisition of Vita Therapeutics and collaborations with academic institutions (per the firm's pipeline disclosures).

### Does CSL Behring participate in fund commitments or only direct deals?

CSL Behring does not participate in third-party fund commitments. All capital deployment is direct, focusing on internal drug development, manufacturing scale-up, and strategic acquisitions that align with its therapeutic areas (per CSL filings).

### Which sectors does CSL Behring explicitly avoid?

CSL Behring focuses exclusively on biotherapeutics for rare and serious diseases within immunology, hematology, cardiovascular and metabolic, respiratory, and transplant areas. It does not invest in other sectors such as digital health, medical devices, diagnostics, or industrial biotechnology (per firm website).

## Related profiles

- [Queen City Fintech](https://altss.com/profile/queen-city-fintech)
- [Grubstakes](https://altss.com/profile/grubstakes)

---

Last updated: 2026-07-10T22:15:01.000Z

Canonical page: https://altss.com/profile/csl-behring

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology